跳转至内容
Merck

L9787

Sigma-Aldrich

L-655,708

≥98% (HPLC), powder

别名:

L-655708, (S)-11,12,13,13a-四氢-7-甲氧基-9-氧代-9H-咪唑并[1,5-a]吡咯并[2,1-c][1,4]苯并二氮杂-1-羧酸乙酯

登录查看公司和协议定价


About This Item

经验公式(希尔记法):
C18H19N3O4
分子量:
341.36
MDL號碼:
分類程式碼代碼:
12352200
PubChem物質ID:
NACRES:
NA.77

化驗

≥98% (HPLC)

形狀

powder

溶解度

DMSO: ≥6.0 mg/mL (Warmed)
H2O: insoluble

起源

Merck & Co., Inc., Kenilworth, NJ, U.S.

SMILES 字串

CCOC(=O)c1ncn2-c3ccc(OC)cc3C(=O)N4CCCC4c12

InChI

1S/C18H19N3O4/c1-3-25-18(23)15-16-14-5-4-8-20(14)17(22)12-9-11(24-2)6-7-13(12)21(16)10-19-15/h6-7,9-10,14H,3-5,8H2,1-2H3/t14-/m0/s1

InChI 密鑰

YKYOQIXTECBVBB-AWEZNQCLSA-N

基因資訊

human ... GABRA5(2558)

應用

L-655,708已被用作α5 GABAA受体反向激动剂,以剂量依赖的方式抑制异丙酚的辨别刺激。

生化/生理作用

L-655,708是 α5 γ-氨基丁酸A型(GABAA)受体的反向激动剂。它具有增加大鼠认知的能力。
对含有α5个亚基的GABAA 受体的苯二氮平类药物位点具有选择性的新型配体。

特點和優勢

《受体分类和信号转导》手册的 GABAA受体页有该化合物的介绍。想要浏览手册的其他页面, 请单击此处
该化合物是由Merck & Co., Inc., Kenilworth, NJ, U.S.开发的。想要浏览其他由制药公司开发的化合物以及已批准药物/候选药物清单, 请单击此处
该化合物是神经科学研究推荐产品。点击此处 ,查看更多神经科学精选产品。想要了解有关生物活性小分子在其他研究领域应用的更多信息,请访问 sigma.com/discover-bsm

儲存類別代碼

11 - Combustible Solids

水污染物質分類(WGK)

WGK 3

閃點(°F)

Not applicable

閃點(°C)

Not applicable

個人防護裝備

Eyeshields, Gloves, type N95 (US)


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

C Sur et al.
Brain research, 822(1-2), 265-270 (1999-03-20)
Multiple subtypes of GABAA receptors are expressed in the rat central nervous system (CNS). To determine the distribution and proportion of alpha5 subunit containing receptors, quantitative autoradiographic analyses were performed with both [3H]L-655,708 and [3H]Ro15-1788, an alpha5 selective and a
Contribution of the alpha5 GABAA receptor to the discriminative stimulus effects of propofol in rat
Wang B, et al.
Neuroreport, 29(5), 347-347 (2018)
José E Hernández-Reyes et al.
Pain, 160(6), 1448-1458 (2019-05-21)
Diabetic neuropathy is an incapacitating complication in diabetic patients. The cellular and molecular mechanisms involved in this pathology are poorly understood. Previous studies have suggested that the loss of spinal GABAergic inhibition participate in painful diabetic neuropathy. However, the role
[3H]L-655,708, a novel ligand selective for the benzodiazepine site of GABAA receptors which contain the α5 subunit.
Quirk, K., et al.
Neuropharmacology, 356, 1331-1335 (1996)
C Sur et al.
Molecular pharmacology, 54(5), 928-933 (1998-11-06)
The gamma-aminobutyric acid (GABA)A receptor is a hetero-oligomer consisting of five subunits, the combination of which confers unique pharmacological properties to the receptor. To understand the physiological role of native GABAA receptors, it is critical to determine their subunit compositions.

商品

DISCOVER Bioactive Small Molecules for Neuroscience

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门